FDMT 4D Molecular Therapeutics Cash per Share

4D Molecular Corp (FDMT) - corporate logo

4D Molecular Therapeutics focuses on R&D without stable revenue streams, consuming capital for research. The current cash per share reflects liquidity dynamics, where 5.49 serves as the current parameter value. The company's prospects are based on precision viral capsids for gene delivery, while exclusive patents for AAV vectors in a strict regulatory environment provide business protection.

4DMT (FDMT): Cash on Hand per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for 4D Molecular Therapeutics, Inc. (FDMT)

- stock value and consensus price forecast:
- cash and cash flow indicators:
Analysis of all company metrics:FDMT, 4D Molecular Therapeutics, Inc.
Core merchandise of 4dmoleculartherapeutics.com

Investors utilize this indicator for liquidity stress testing, assessing the capital balance per share as a buffer against bankruptcy. For 4D Molecular Therapeutics (FDMT), which develops gene therapies through pharmaceutical alliances, the cash per share figure reflects the ability to fund costly clinical trials without emergency equity issuance, determining the business's financial stability during the product commercialization phase.

Who 4D Molecular Therapeutics competes with

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology